JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Billiontoone (NASDAQ:BLLN) Stock

Billiontoone (NASDAQ:BLLN) had its price objective raised by equities research analysts at JPMorgan Chase & Co. from $130.00 to $135.00 in a report released on Thursday, Benzinga reports. The brokerage currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target suggests a potential upside of 18.48% from the stock’s previous close.

Several other analysts have also weighed in on BLLN. Canaccord Genuity Group initiated coverage on shares of Billiontoone in a research note on Wednesday, September 2nd. They set a “buy” rating and a $120.00 target price for the company. BTIG Research restated a “buy” rating and issued a $130.00 price target on shares of Billiontoone in a research report on Thursday. Wall Street Zen lowered shares of Billiontoone from a “buy” rating to a “hold” rating in a report on Saturday, August 8th. Guggenheim boosted their price objective on shares of Billiontoone from $125.00 to $128.00 and gave the company a “buy” rating in a research report on Thursday, October 1st. Finally, Zacks Research raised shares of Billiontoone from a “strong sell” rating to a “hold” rating in a research report on Friday, October 2nd. Seven research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Billiontoone presently has an average rating of “Moderate Buy” and an average price target of $126.88.

Billiontoone Stock Performance

Shares of NASDAQ BLLN traded up $1.55 during trading on Thursday, reaching $113.94. The stock had a trading volume of 993,248 shares, compared to its average volume of 507,007. Billiontoone has a one year low of $61.96 and a one year high of $150.44. The company has a debt-to-equity ratio of 0.17, a quick ratio of 11.31 and a current ratio of 11.69. The stock has a market cap of $5.38 billion and a PE ratio of 123.85. The firm’s 50 day moving average price is $105.37 and its two-hundred day moving average price is $97.15.

Billiontoone (NASDAQ:BLLN) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $0.15 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.15. The firm had revenue of $109.45 million for the quarter. Billiontoone had a return on equity of 9.96% and a net margin of 8.04%. On average, research analysts forecast that Billiontoone will post 0.80 earnings per share for the current fiscal year.

Insider Buying and Selling at Billiontoone

In other news, SVP Bosch John Roderick Ten sold 2,834 shares of the company’s stock in a transaction dated Monday, November 2nd. The shares were sold at an average price of $113.17, for a total transaction of $320,723.78. Following the completion of the transaction, the senior vice president owned 16,551 shares in the company, valued at approximately $1,873,076.67. This represents a 14.62% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Oguzhan Atay sold 25,001 shares of the stock in a transaction dated Monday, November 2nd. The stock was sold at an average price of $109.24, for a total transaction of $2,731,109.24. Following the completion of the sale, the chief executive officer directly owned 16,667 shares in the company, valued at approximately $1,820,703.08. This trade represents a 60.00% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 264,194 shares of company stock worth $27,797,333. 50.22% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of BLLN. Parallel Advisors LLC grew its position in Billiontoone by 86.7% in the 3rd quarter. Parallel Advisors LLC now owns 280 shares of the company’s stock worth $30,000 after purchasing an additional 130 shares during the last quarter. Integrated Wealth Concepts LLC acquired a new stake in shares of Billiontoone in the second quarter valued at approximately $29,000. Toth Financial Advisory Corp increased its stake in shares of Billiontoone by 60.0% in the third quarter. Toth Financial Advisory Corp now owns 800 shares of the company’s stock valued at $85,000 after purchasing an additional 300 shares during the period. MCF Advisors LLC raised its holdings in shares of Billiontoone by 330.8% during the second quarter. MCF Advisors LLC now owns 448 shares of the company’s stock valued at $54,000 after buying an additional 344 shares during the last quarter. Finally, Family Legacy Financial Solutions LLC bought a new stake in shares of Billiontoone during the third quarter valued at approximately $53,000.

More Billiontoone News

Here are the key news stories impacting Billiontoone this week:

• Positive Sentiment: Q3 results beat expectations: BillionToOne reported earnings of $0.32 per share versus a $0.16 consensus estimate, while revenue also topped analyst expectations. Q3 earnings report
• Positive Sentiment: Higher 2026 revenue outlook and upcoming product: The company raised its full-year revenue guidance to $460 million–$470 million and plans to launch Northstar Clear on December 15, giving investors signs of growth and a near-term product catalyst. Outlook and product launch
• Positive Sentiment: Analysts remain constructive: JPMorgan raised its price target from $130 to $135 and maintained an Overweight rating; BTIG reaffirmed its Buy rating with a $130 target. JPMorgan price-target change
• Negative Sentiment: Several executives sold shares: The CEO, CTO and an SVP disclosed sales, including a substantial reduction in the CTO’s reported holdings. The transactions were conducted under pre-arranged Rule 10b5-1 plans, which may temper concerns but could still weigh on sentiment. Insider sale report

Billiontoone Company Profile

BillionToOne, Inc is a molecular diagnostics company that develops tests designed to provide more sensitive and quantitative genetic information from blood samples. The company’s technology is based on its proprietary Quantitative Counting Template (QCT) platform, which is designed to measure DNA molecules with high sensitivity and support the detection of clinically meaningful genetic signals.

The company’s products include prenatal diagnostic and screening solutions marketed under the UNITY brand.